NCT02694341

Brief Summary

The Bakri intrauterine balloon can achieve haemostasis in cases of postpartum haemorrhage, including haemorrhage associated with placenta previa by compressing the lower uterine segment.

Trial Health

30
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Timeline
Completed

Started Dec 2018

Geographic Reach
1 country

1 active site

Status
withdrawn

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

February 24, 2016

Completed
5 days until next milestone

First Posted

Study publicly available on registry

February 29, 2016

Completed
2.8 years until next milestone

Study Start

First participant enrolled

December 1, 2018

Completed
11 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

November 1, 2019

Completed
1 month until next milestone

Study Completion

Last participant's last visit for all outcomes

December 1, 2019

Completed
Last Updated

May 28, 2020

Status Verified

May 1, 2020

Enrollment Period

11 months

First QC Date

February 24, 2016

Last Update Submit

May 26, 2020

Conditions

Keywords

Management

Outcome Measures

Primary Outcomes (1)

  • Percentages of failure of Bakri Balloon either rupture of balloon or slippage of balloon.

    24 hours

Study Arms (2)

Bakri Balloon with abdominal traction stitch

ACTIVE COMPARATOR

bakri balloon will be inserted with abdominal traction stitch

Procedure: Abdominal traction stitchDevice: Bakri Balloon

Bakri Balloon without abdominal traction stitch

EXPERIMENTAL

bakri balloon will be inserted with no performance of abdominal traction stitch

Device: Bakri Balloon

Interventions

Abdominal traction stitch to prevent prolapse of the Bakri balloon. A suture is tied through the uterine end shaft hole of the Bakri balloon. The other end of the suture is placed through the uterine wall. The balloon is positioned in the lower segment.The abdominal traction stitch is held by forceps and fixed, with cephalad traction applied continuously to the balloon, preventing balloon prolapse.The abdominal traction stitch is fixed by an umbilical cord clamp on the abdominal wall, preventing the suture from receding into the abdominal cavity, and, thus, maintaining the correct position of the balloon and preventing prolapse. Removal of the balloon is easy, with no resistance; the suture does not hinder balloon removal. At the time of balloon removal, the suture that was placed through the abdominal wall will traverse the intra-abdominal and intrauterine cavities, and should be kept clean.

Bakri Balloon with abdominal traction stitch

uterine compression balloon

Bakri Balloon with abdominal traction stitchBakri Balloon without abdominal traction stitch

Eligibility Criteria

Sexfemale
Healthy VolunteersNo
Age GroupsChild (0-17), Adult (18-64), Older Adult (65+)

You may qualify if:

  • All women delivered and presented with primary atonic PPH
  • Women who accepted to participate

You may not qualify if:

  • Traumatic PPH as excluded by examination under anesthesia.
  • With any suspected or clinical evidence of uterine infection
  • Women diagnosed to have preeclampsia or eclampsia after delivery.
  • Women who had DM during pregnancy
  • Women with history of DVT or other thromboembolic complication
  • Women with history of rheumatic heart disease.
  • Women with coagulation defects.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Ahmed Abbas

Assiut, Cairo Governorate, 002, Egypt

Location

Related Publications (1)

  • Kellie FJ, Wandabwa JN, Mousa HA, Weeks AD. Mechanical and surgical interventions for treating primary postpartum haemorrhage. Cochrane Database Syst Rev. 2020 Jul 1;7(7):CD013663. doi: 10.1002/14651858.CD013663.

MeSH Terms

Conditions

HemorrhagePlacenta Previa

Condition Hierarchy (Ancestors)

Pathologic ProcessesPathological Conditions, Signs and SymptomsObstetric Labor ComplicationsPregnancy ComplicationsFemale Urogenital Diseases and Pregnancy ComplicationsUrogenital DiseasesPlacenta Diseases
0

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
SINGLE
Who Masked
PARTICIPANT
Purpose
TREATMENT
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Dr

Study Record Dates

First Submitted

February 24, 2016

First Posted

February 29, 2016

Study Start

December 1, 2018

Primary Completion

November 1, 2019

Study Completion

December 1, 2019

Last Updated

May 28, 2020

Record last verified: 2020-05

Data Sharing

IPD Sharing
Will share

Locations